Abstract
The purified BCP61 was reported to be a unique low-molecular-weight (MW) anti-microbial peptide because of its non-identical alanine-rich N-terminal sequence. In this study, we investigated the anti-inflammatory effects of BCP61 on induction of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), pro-inflammatory cytokines, nuclear factor-kappa B (NF-κB), and mitogen-activated protein kinases (MAPKs) in lipopolysaccharide (LPS)-stimulated Raw 264.7 cells. The treatment with BCP61, with varying concentrations of 10, 50, and 100 μg/mL, inhibited levels of expression of LPS-induced NF-κB and MAPKs (extracellular signal-related kinases (ERKs), c-Jun NH2-terminal kinase (JNK), and mitogen-activated protein (p38)) as well as production of pro-inflammatory mediators, such as nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). The results suggested that BCP61 prevents inhibitor of kappa B (IκBα) phosphorylation and degradation, thereby inhibiting the nuclear translocation of the p65 protein. We do report that the use of BCP61 in the treatment of inflammation as well as microbial infection could be a potent therapeutic candidate.
Similar content being viewed by others
References
Korhonen, H., and A. Pihlanto. 2006. Bioactive peptides: production and functionality. International Dairy Journal 16(9): 945–960.
Oseguera-Toledo, M.E., E.G. de Mejia, V.P. Dia, and S.L. Amaya-Llano. 2011. Common bean (Phaseolus vulgaris L.) hydrolysates inhibit inflammation in LPS-induced macrophages through suppression of NF-κB pathways. Food Chemistry 127(3): 1175–1185.
Ahn, C.-B., Y.-S. Cho, and J.-Y. Je. 2015. Purification and anti-inflammatory action of tripeptide from salmon pectoral fin byproduct protein hydrolysate. Food Chemistry 168: 151–156.
Kim, E.K., S.-Y. An, M.-S. Lee, T.H. Kim, H.-K. Lee, W.S. Hwang, S.J. Choe, T.-Y. Kim, S.J. Han, and H.J. Kim. 2011. Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients. Nutrition Research 31(6): 436–443.
Islam, M.S., and H. Choi. 2009. Antidiabetic effect of Korean traditional Baechu (Chinese cabbage) kimchi in a type 2 diabetes model of rats. Journal of Medicinal Food 12(2): 292–297.
Nose, F., T. Ichikawa, M. Fujiwara, and I. Okayasu. 2002. Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors. American Journal of Clinical Pathology 117(4): 546–551.
Klimp, A.H., H. Hollema, C. Kempinga, A.G. van der Zee, E.G. de Vries, and T. Daemen. 2001. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Research 61(19): 7305–7309.
Mosser, D.M., and X. Zhang. 2008. Interleukin‐10: new perspectives on an old cytokine. Immunological Reviews 226(1): 205–218.
Ohshima, H. 2003. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicology Letters 140: 99–104.
Farrow, B., and B.M. Evers. 2002. Inflammation and the development of pancreatic cancer. Surgical Oncology 10(4): 153–169.
Keum, Y.-S., S.S. Han, K.-S. Chun, K.-K. Park, J.-H. Park, S.K. Lee, and Y.-J. Surh. 2003. Inhibitory effects of the ginsenoside Rg 3 on phorbol ester-induced cyclooxygenase-2 expression, NF-κB activation and tumor promotion. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523: 75–85.
Karin, M., Y. Cao, F.R. Greten, and Z.-W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nature Reviews. Cancer 2(4): 301–310.
Huang, P., J. Han, and L. Hui. 2010. MAPK signaling in inflammation-associated cancer development. Protein & Cell 1(3): 218–226.
Karin, M. 2006. Nuclear factor-κB in cancer development and progression. Nature 441(7092): 431–436.
Choi, Y.H., S.S. Cho, J.R. Simkhada, and J.C. Yoo. 2012. A novel thermotolerant and acidotolerant peptide produced by a Bacillus strain newly isolated from a fermented food (kimchi) shows activity against multidrug-resistant bacteria. International Journal of Antimicrobial Agents 40(1): 80–83.
Wadsworth, T.L., and D.R. Koop. 1999. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochemical Pharmacology 57(8): 941–949.
Kovacs-Nolan, J., H. Zhang, M. Ibuki, T. Nakamori, K. Yoshiura, P.V. Turner, T. Matsui, and Y. Mine. 2012. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochimica et Biophysica Acta (BBA)-General Subjects 1820(11): 1753–1763.
Li, J., M.A. D’Annibale-Tolhurst, K.B. Adler, S. Fang, Q. Yin, A.J. Birkenheuer, M.G. Levy, S.L. Jones, E.J. Sung, and E.C. Hawkins. 2013. A myristoylated alanine-rich C kinase substrate–related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils. American Journal of Respiratory Cell and Molecular Biology 48(3): 314–321.
Teixeira, L.D., O.N. Silva, L. Migliolo, I.C. Fensterseifer, and O.L. Franco. 2013. In vivo antimicrobial evaluation of an alanine-rich peptide derived from Pleuronectes americanus. Peptides 42: 144–148.
Murakami, A., and H. Ohigashi. 2007. Targeting NOX, INOS and COX‐2 in inflammatory cells: chemoprevention using food phytochemicals. International Journal of Cancer 121(11): 2357–2363.
An, S.J., H.O. Pae, G.S. Oh, B.M. Choi, S. Jeong, S.I. Jang, H. Oh, T.O. Kwon, C.E. Song, and H.T. Chung. 2002. Inhibition of TNF-alpha, IL-1beta, and IL-6 productions and NF-kappa B activation in lipopolysaccharide-activated RAW 264.7 macrophages by catalposide, an iridoid glycoside isolated from Catalpa ovata G. Don (Bignoniaceae). International Immunopharmacology 2(8): 1173–1181.
Kim, E.H., B. Shim, S. Kang, G. Jeong, J.-S. Lee, Y.-B. Yu, and M. Chun. 2009. Anti-inflammatory effects of Scutellaria baicalensis extract via suppression of immune modulators and MAP kinase signaling molecules. Journal of Ethnopharmacology 126(2): 320–331.
Min, K.R., H. Lee, B.H. Kim, E. Chung, S.M. Cho, and Y. Kim. 2005. Inhibitory effect of 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide on nitric oxide and interleukin-6 production in macrophages. Life Sciences 77(25): 3242–3257.
Kyriakis, J.M., and J. Avruch. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. Journal of Biological Chemistry 271(40): 24313–24316.
Xiao, Z.-Y., W.-X. Zhou, Y.-X. Zhang, J.-P. Cheng, J.-F. He, R.-F. Yang, and L.-H. Yun. 2007. Inhibitory effect of linomide on lipopolysaccharide-induced proinflammatory cytokine tumor necrosis factor-alpha production in RAW264. 7 macrophages through suppression of NF-κB, p38, and JNK activation. Immunology Letters 114(2): 81–85.
Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13(2): 85–94.
Hacker, H., and M. Karin. 2006. Regulation and function of IKK and IKK-related kinases. Science’s STKE 357(13): 12–14.
Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18(49): 6867–6874.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Funding
This work was supported by research fund from Chosun University, 2016.
Competing interests
The authors declare that they have no competing interests.
Ethical approval
Not required.
Additional information
Yun Hee Choi and Yoon Seok Choi contributed equally to this work.
Rights and permissions
About this article
Cite this article
Choi, Y.H., Choi, Y.S., Kim, Y.K. et al. A multifunctional alanine-rich anti-inflammatory peptide BCP61 showed potent inhibitory effects by inhibiting both NF-κB and MAPK expression. Inflammation 40, 688–696 (2017). https://doi.org/10.1007/s10753-017-0515-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-017-0515-7